From the Newsroom| Fourth Ranbaxy plant under FDA scrutiny

Mint 2018-02-16

Views 2

Mint's CH Unnikrishnan talks about the trouble drug maker Ranbaxy is facing with the US regulator.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Dinesh Thakur on Ranbaxy US FDA case
play
04:55

Dinesh Thakur on Ranbaxy US FDA case
Ranbaxy accused of gaming FDA rules to thwart rival drug makers
play
01:17

Ranbaxy accused of gaming FDA rules to thwart rival drug makers
Food at Siddhivinayak, Tirupati temples to come under regulator's scrutiny
play
01:50

Food at Siddhivinayak, Tirupati temples to come under regulator's scrutiny
More than 300,000 Volkswagen cars under scrutiny in India
play
01:28

More than 300,000 Volkswagen cars under scrutiny in India
Title: From the Newsroom: Violence at Maruti's Manesar plant
play
03:40

Title: From the Newsroom: Violence at Maruti's Manesar plant
From the newsroom: Tata Capital to bring insurance, AMC firms under its fold
play
02:29

From the newsroom: Tata Capital to bring insurance, AMC firms under its fold
From the Newsroom: Banks will lend to students under management quota
play
05:06

From the Newsroom: Banks will lend to students under management quota
From the Newsroom | L&T to sell thermal plant in Punjab
play
03:41

From the Newsroom | L&T to sell thermal plant in Punjab
From the newsroom: Private-equity
play
02:55

From the newsroom: Private-equity
From the Newsroom: Costly fertilizers
play
04:16

From the Newsroom: Costly fertilizers
From the Newsroom: The Section 66a debate
play
06:24

From the Newsroom: The Section 66a debate
From the Newsroom: What will RBI do?
play
02:41

From the Newsroom: What will RBI do?